LoXL4 is induced by transforming growth factor β1 through Smad and JunB/Fra2 and contributes to vascular matrix remodeling

Molecular and Cellular Biology

Volumn 33, Issue 12, 2013, Pages 2388-2401

  Busnadiego, Oscar ^a   González Santamaría, José ^a   Lagares, David ^b   Guinea Viniegra, Juan ^c   Pichol Thievend, Cathy ^c   Muller, Laurent ^a   Rodríguez Pascual, Fernando ^a  

^a CSIC   (Spain)

^b Centro Nacional de Investigaciones Oncológicas   (Spain)

^c l'alimentation et l'Environnement   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LYSYL OXIDASE LIKE 4; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN LYSINE 6 OXIDASE; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FRA 2; TRANSCRIPTION FACTOR JUNB; TRANSCRIPTION FACTOR SP1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; COW; CPG ISLAND; DIMERIZATION; ENHANCER REGION; EXON; EXTRACELLULAR MATRIX; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; UPREGULATION;

ANIMALS; AORTA; BASE SEQUENCE; BINDING SITES; CATTLE; CELLS, CULTURED; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FOS-RELATED ANTIGEN-2; HEK293 CELLS; HUMANS; MICE; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN-LYSINE 6-OXIDASE; RECOMBINANT PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SEQUENCE ALIGNMENT; SMAD PROTEINS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84878981312     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00036-13     Document Type: Article

References (72)

1. Wu MY, Hill CS. 2009. Tgf-beta superfamily signaling in embryonic development and homeostasis. Dev. Cell 16:329-343.
2. Attisano L, Wrana JL. 2002. Signal transduction by the TGF-beta superfamily. Science 296:1646-1647.
3. Leask A, Abraham DJ. 2004. TGF-beta signaling and the fibrotic response. FASEB J. 18:816-827.
4. Ruiz-Ortega M, Rodriguez-Vita J, Sanchez-Lopez E, Carvajal G, Egido J. 2007. TGF-beta signaling in vascular fibrosis. Cardiovasc. Res. 74:196- 206.
5. Graham HK, Akhtar R, Kridiotis C, Derby B, Kundu T, Trafford AW, Sherratt MJ. 2011. Localised micro-mechanical stiffening in the ageing aorta. Mech. Ageing Dev. 132:459-467.
6. Pick R, Jalil JE, Janicki JS, Weber KT. 1989. The fibrillar nature and structure of isoproterenol-induced myocardial fibrosis in the rat. Am. J. Pathol. 134:365-371.
7. Lindeman JH, Ashcroft BA, Beenakker JW, van Es M, Koekkoek NB, Prins FA, Tielemans JF, Abdul-Hussien H, Bank RA, Oosterkamp TH. 2010. Distinct defects in collagen microarchitecture underlie vessel-wall failure in advanced abdominal aneurysms and aneurysms in Marfan syndrome. Proc. Natl. Acad. Sci. U. S. A. 107:862- 865.
8. Birk DE, Bruckner P. 2011. Collagens, suprastructures, and collagen fibril assembly, p 1-39. In Mecham RP (ed), The extracellular matrix: an overview. Springer-Verlag, Berlin, Germany.
9. Maki JM. 2009. Lysyl oxidases in mammalian development and certain pathological conditions. Histol. Histopathol. 24:651- 660.
10. Liu X, Zhao Y, Gao J, Pawlyk B, Starcher B, Spencer JA, Yanagisawa H, Zuo J, Li T. 2004. Elastic fiber homeostasis requires lysyl oxidase-like 1 protein. Nat. Genet. 36:178-182.
11. Maki JM, Rasanen J, Tikkanen H, Sormunen R, Makikallio K, Kivirikko KI, Soininen R. 2002. Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice. Circulation 106:2503-2509.
12. Rodriguez-Pascual F, Redondo-Horcajo M, Lamas S. 2003. Functional cooperation between Smad proteins and activator protein-1 regulates transforming growth factor-beta-mediated induction of endothelin-1 expression. Circ. Res. 92:1288-1295.
13. Piek E, Ju WJ, Heyer J, Escalante-Alcalde D, Stewart CL, Weinstein M, Deng C, Kucherlapati R, Bottinger EP, Roberts AB. 2001. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts. J. Biol. Chem. 276:19945-19953.
14. Rodriguez-Pascual F, Redondo-Horcajo M, Magan-Marchal N, Lagares D, Martinez-Ruiz A, Kleinert H, Lamas S. 2008. Glyceraldehyde-3- phosphate dehydrogenase regulates endothelin-1 expression by a novel, redox-sensitive mechanism involving mRNA stability. Mol. Cell. Biol. 28: 7139-7155.
15. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
16. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402- 408.
17. Matsuo K, Owens JM, Tonko M, Elliott C, Chambers TJ, Wagner EF. 2000. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat. Genet. 24:184-187.
18. Bakiri L, Matsuo K, Wisniewska M, Wagner EF, Yaniv M. 2002. Promoter specificity and biological activity of tethered AP-1 dimers. Mol. Cell. Biol. 22:4952- 4964.
19. Ovcharenko I, Loots GG, Giardine BM, Hou M, Ma J, Hardison RC, Stubbs L, Miller W. 2005. Mulan: multiple-sequence local alignment and visualization for studying function and evolution. Genome Res. 15:184- 194.
20. Schreiber E, Matthias P, Muller MM, Schaffner W. 1989. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17:6419.
21. Shevchenko A, Wilm M, Vorm O, Mann M. 1996. Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal. Chem. 68:850-858.
22. Lagares D, Busnadiego O, Garcia-Fernandez RA, Kapoor M, Liu S, Carter DE, Abraham DJ, Shi-Wen X, Carreira P, Fontaine BA, Shea BS, Tager AM, Leask A, Lamas S, Rodriguez-Pascual F. 2012. Inhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation. Arthritis Rheum. 64:1653-1664.
23. Artym VV, Matsumoto K. 2010. Imaging cells in three-dimensional collagen matrix. Curr. Protoc. Cell Biol. Chapter 10:Unit 10.18.1- 10.18.20.
24. Palamakumbura AH, Trackman PC. 2002. A fluorometric assay for detection of lysyl oxidase enzyme activity in biological samples. Anal. Biochem. 300:245-251.
25. Gorogh T, Holtmeier C, Weise JB, Hoffmann M, Ambrosch P, Laudien M, Csiszar K. 2008. Functional analysis of the 5= flanking domain of the LOXL4 gene in head and neck squamous cell carcinoma cells. Int. J. Oncol. 33:1091-1098.
26. Kim DJ, Lee DC, Yang SJ, Lee JJ, Bae EM, Kim DM, Min SH, Kim SJ, Kang DC, Sang BC, Myung PK, Park KC, Yeom YI. 2008. Lysyl oxidase like 4, a novel target gene of TGF-beta1 signaling, can negatively regulate TGF-beta1-induced cell motility in PLC/PRF/5 hepatoma cells. Biochem. Biophys. Res. Commun. 373:521-527.
27. Sundqvist A, Zieba A, Vasilaki E, Herrera Hidalgo C, Soderberg O, Koinuma D, Miyazono K, Heldin CH, Landegren U, Ten Dijke P, van Dam H. 27 August 2012. Specific interactions between Smad proteins and AP-1 components determine TGFbeta-induced breast cancer cell invasion. Oncogene doi:10.1038/onc.2012.370.
28. Chung K-Y, Agarwal A, Uitto J, Mauviel A. 1996. An AP-1 binding sequence is essential for regulation of the human 2(I) collagen (COL1A2) promoter activity by transforming growth factor. J. Biol. Chem. 271:3272- 3278.
29. Macleod D, Charlton J, Mullins J, Bird AP. 1994. Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev. 8:2282-2292.
30. Derynck R, Zhang YE. 2003. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425:577-584.
31. Matthews CP, Birkholz AM, Baker AR, Perella CM, Beck GR Jr, Young MR, Colburn NH. 2007. Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis. Cancer Res. 67:2430-2438.
32. Moustakas A, Heldin CH. 2009. The regulation of TGFbeta signal transduction. Development 136:3699-3714.
33. Eferl R, Hasselblatt P, Rath M, Popper H, Zenz R, Komnenovic V, Idarraga MH, Kenner L, Wagner EF. 2008. Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1. Proc. Natl. Acad. Sci. U. S. A. 105:10525-10530.
34. Maurer B, Busch N, Jungel A, Pileckyte M, Gay RE, Michel BA, Schett G, Gay S, Distler J, Distler O. 2009. Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis. Circulation 120:2367-2376.
35. Maurer B, Reich N, Juengel A, Kriegsmann J, Gay RE, Schett G, Michel BA, Gay S, Distler JH, Distler O. 2012. Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis. Ann. Rheum. Dis. 71:1382-1387.
36. Reich N, Maurer B, Akhmetshina A, Venalis P, Dees C, Zerr P, Palumbo K, Zwerina J, Nevskaya T, Gay S, Distler O, Schett G, Distler JH. 2010. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis. Arthritis Rheum. 62:280-290.
37. O'Shea EK, Rutkowski R, Kim PS. 1992. Mechanism of specificity in the Fos-Jun oncoprotein heterodimer. Cell 68:699-708.
38. Murakami M, Sonobe MH, Ui M, Kabuyama Y, Watanabe H, Wada T, Handa H, Iba H. 1997. Phosphorylation and high level expression of Fra-2 in v-src transformed cells: a pathway of activation of endogenous AP-1. Oncogene 14:2435-2444.
39. Murakami M, Ui M, Iba H. 1999. Fra-2-positive autoregulatory loop triggered by mitogen-activated protein kinase (MAPK) and Fra-2 phosphorylation sites by MAPK. Cell Growth Differ. 10:333-342.
40. Husberg C, Agnetti G, Holewinski RJ, Christensen G, Van Eyk JE. 2012. Dephosphorylation of cardiac proteins in vitro-a matter of phosphatase specificity. Proteomics 12:973-978.
41. Sebolt-Leopold JS, Dudley DT, Herrera R, Van Becelaere K, Wiland A, Gowan RC, Tecle H, Barrett SD, Bridges A, Przybranowski S, Leopold WR, Saltiel AR. 1999. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat. Med. 5:810-816.
42. Asuncion L, Fogelgren B, Fong KS, Fong SF, Kim Y, Csiszar K. 2001. A novel human lysyl oxidase-like gene (LOXL4) on chromosome 10q24 has an altered scavenger receptor cysteine rich domain. Matrix Biol. 20:487-491.
43. Ito H, Akiyama H, Iguchi H, Iyama K, Miyamoto M, Ohsawa K, Nakamura T. 2001. Molecular cloning and biological activity of a novel lysyl oxidase- related gene expressed in cartilage. J. Biol. Chem. 276:24023-24029.
44. Maki JM, Tikkanen H, Kivirikko KI. 2001. Cloning and characterization of a fifth human lysyl oxidase isoenzyme: the third member of the lysyl oxidase-related subfamily with four scavenger receptor cysteine-rich domains. Matrix Biol. 20:493- 496.
45. Barker HE, Cox TR, Erler JT. 2012. The rationale for targeting the LOX family in cancer. Nat. Rev. Cancer 12:540-552.
46. Lopez B, Gonzalez A, Hermida N, Valencia F, de Teresa E, Diez J. 2010. Role of lysyl oxidase in myocardial fibrosis: from basic science to clinical aspects. Am. J. Physiol. Heart Circ. Physiol. 299:H1-H9.
47. Gacheru SN, Thomas KM, Murray SA, Csiszar K, Smith-Mungo LI, Kagan HM. 1997. Transcriptional and post-transcriptional control of lysyl oxidase expression in vascular smooth muscle cells: effects of TGF-Î21 and serum deprivation. J. Cell. Biochem. 65:395-407.
48. Boak AM, Roy R, Berk J, Taylor L, Polgar P, Goldstein RH, Kagan HM. 1994. Regulation of lysyl oxidase expression in lung fibroblasts by transforming growth factor-beta 1 and prostaglandin E2. Am. J. Respir. Cell Mol. Biol. 11:751-755.
49. Sethi A, Mao W, Wordinger RJ, Clark AF. 2011. Transforming growth factor-beta induces extracellular matrix protein cross-linking lysyl oxidase (LOX) genes in human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 52:5240-5250.
50. Wang Y, Fortin JRM, Lamba P, Bonomi M, Persani L, Roberson MS, Bernard DJ. 2008. Activator protein-1 and Smad proteins synergistically regulate human follicle-stimulating hormone Î2-promoter activity. Endocrinology 149:5577-5591.
51. Herzer K, Grosse-Wilde A, Krammer PH, Galle PR, Kanzler S. 2008. Transforming growth factor-beta-mediated tumor necrosis factor-related apoptosis-inducing ligand expression and apoptosis in hepatoma cells requires functional cooperation between Smad proteins and activator protein-1. Mol. Cancer Res. 6:1169-1177.
52. Koinuma D, Tsutsumi S, Kamimura N, Taniguchi H, Miyazawa K, Sunamura M, Imamura T, Miyazono K, Aburatani H. 2009. Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor beta signaling. Mol. Cell. Biol. 29:172-186.
53. Dermitzakis ET, Clark AG. 2002. Evolution of transcription factor binding sites in mammalian gene regulatory regions: conservation and turnover. Mol. Biol. Evol. 19:1114-1121.
54. Stratton R, Rajkumar V, Ponticos M, Nichols B, Shiwen X, Black CM, Abraham DJ, Leask A. 2002. Prostacyclin derivatives prevent the fibrotic response to TGF-beta by inhibiting the Ras/MEK/ERK pathway. FASEB J. 16:1949-1951.
55. de Boer RA, Pokharel S, Flesch M, van Kampen DA, Suurmeijer AJ, Boomsma F, van Gilst WH, van Veldhuisen DJ, Pinto YM. 2004. Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27. J. Mol. Med. (Berl.) 82:678-687.
56. Nakerakanti S, Trojanowska M. 2012. The role of TGF-beta receptors in fibrosis. Open Rheumatol. J. 6:156-162.
57. Gervasi M, Bianchi-Smiraglia A, Cummings M, Zheng Q, Wang D, Liu S, Bakin AV. 2012. JunB contributes to Id2 repression and the epithelialto-mesenchymal transition in response to transforming growth factorbeta. J. Cell Biol. 196:589-603.
58. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB, Neilson EG, Sayegh MH, Izumo S, Kalluri R. 2007. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 13:952-961.
59. Piera-Velazquez S, Li Z, Jimenez SA. 2011. Role of endothelialmesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am. J. Pathol. 179:1074-1080.
60. Arciniegas E, Sutton AB, Allen TD, Schor AM. 1992. Transforming growth factor beta 1 promotes the differentiation of endothelial cells into smooth muscle-like cells in vitro. J. Cell Sci. 103:521-529.
61. Arciniegas E, Frid MG, Douglas IS, Stenmark KR. 2007. Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol. 293:L1-L8.
62. Frid MG, Kale VA, Stenmark KR. 2002. Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis. Circ. Res. 90:1189-1196.
63. Ishisaki A, Hayashi H, Li AJ, Imamura T. 2003. Human umbilical vein endothelium-derived cells retain potential to differentiate into smooth muscle-like cells. J. Biol. Chem. 278:1303-1309.
64. Spin JM, Nallamshetty S, Tabibiazar R, Ashley EA, King JY, Chen M, Tsao PS, Quertermous T. 2004. Transcriptional profiling of in vitro smooth muscle cell differentiation identifies specific patterns of gene and pathway activation. Physiol. Genomics 19:292-302.
65. Varon C, Tatin F, Moreau V, Van Obberghen-Schilling E, Fernandez-Sauze S, Reuzeau E, Kramer I, Genot E. 2006. Transforming growth factor beta induces rosettes of podosomes in primary aortic endothelial cells. Mol. Cell. Biol. 26:3582-3594.
66. Rottiers P, Saltel F, Daubon T, Chaigne-Delalande B, Tridon V, Billottet C, Reuzeau E, Genot E. 2009. TGFbeta-induced endothelial podosomes mediate basement membrane collagen degradation in arterial vessels. J. Cell Sci. 122:4311-4318.
67. Khoshnoodi J, Pedchenko V, Hudson BG. 2008. Mammalian collagen IV. Microsc. Res. Tech. 71:357-370.
68. Eyre DR, Wu JJ. 2010. Collagen crosslinks. Top. Curr. Chem. 247:207-229.
69. Bignon M, Pichol-Thievend C, Hardouin J, Malbouyres M, Brechot N, Nasciutti L, Barret A, Teillon J, Guillon E, Etienne E, Caron M, Joubert-Caron R, Monnot C, Ruggiero F, Muller L, Germain S. 2011. Lysyl oxidase-like protein-2 regulates sprouting angiogenesis and type IV collagen assembly in the endothelial basement membrane. Blood 118: 3979-3989.
70. Kleinman HK, McGarvey ML, Liotta LA, Robey PG, Tryggvason K, Martin GR. 1982. Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 21:6188-6193.
71. Sarrias MR, Gronlund J, Padilla O, Madsen J, Holmskov U, Lozano F. 2004. The scavenger receptor cysteine-rich (SRCR) domain: an ancient and highly conserved protein module of the innate immune system. Crit. Rev. Immunol. 24:1-37.
72. Kim YM, Kim EC, Kim Y. 2011. The human lysyl oxidase-like 2 protein functions as an amine oxidase toward collagen and elastin. Mol. Biol. Rep. 38:145-149.